These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9335362)

  • 1. LDL hemoperfusion--a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients.
    Bosch T; Schmidt B; Kleophas W; Otto V; Samtleben W
    Artif Organs; 1997 Oct; 21(10):1060-5. PubMed ID: 9335362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood.
    Bosch T; Schmidt B; Kleophas W; Gillen C; Otto V; Passlick-Deetjen J; Gurland HJ
    Artif Organs; 1997 Sep; 21(9):977-82. PubMed ID: 9288867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood.
    Bosch T; Lennertz A; Schmidt B; Fink E; Keller C; Toepfer M; Dräger J; Samtleben W
    Artif Organs; 2000 Feb; 24(2):81-90. PubMed ID: 10718759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood.
    Bosch T; Schmidt B; Blumenstein M; Gurland HJ
    Artif Organs; 1993 Jul; 17(7):640-52. PubMed ID: 8338441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low-dose citrate anticoagulation on the clinical safety and efficacy of direct adsorption of lipoproteins (DALI apheresis) in hypercholesterolemic patients: a prospective controlled clinical trial.
    Bosch T; Heinemann O; Duhr C; Wendler T; Keller C; Fink E; Kirschner T; Klebert S; Samtleben W
    Artif Organs; 2000 Oct; 24(10):790-6. PubMed ID: 11091168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center.
    Bosch T; Lennertz A; Kordes B; Samtleben W
    Ther Apher; 1999 Aug; 3(3):209-13. PubMed ID: 10427617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-free DALI LDL-apheresis in hyperlipidemic patients: efficacy, safety and biocompatibility.
    Wendler T; Lennertz A; Heinemann O; Duhr C; Samtleben W; Bosch T
    Int J Artif Organs; 2000 Oct; 23(10):710-7. PubMed ID: 11075902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct adsorption of lipoproteins from whole blood by DALI apheresis: technique and effects.
    Bosch T
    Ther Apher; 2001 Aug; 5(4):239-43. PubMed ID: 11724507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified DALI LDL-apheresis using trisodium citrate anticoagulation plus bicarbonate or lactate-buffered hemofiltration substitution fluids as primers.
    Bosch T; Wendler T; Maschke H
    Artif Organs; 2003 Jun; 27(6):555-64. PubMed ID: 12780510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein hemoperfusion using a modified polyacrylate adsorber: in vitro, ex vivo, and first clinical results.
    Bosch T
    Artif Organs; 1996 Apr; 20(4):344-5. PubMed ID: 9139622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T; Lennertz A; Schenzle D; Dräger J;
    J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct effects of LDL apheresis by hemoperfusion (DALI) and heparin-induced extracorporeal precipitation (HELP) on leukocyte respiratory burst activity of patients with familial hypercholesterolemia.
    Kopprasch S; Julius U; Gromeier S; Kühne H; Graessler J
    J Clin Apher; 2000; 15(4):249-55. PubMed ID: 11124693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-efficiency DALI apheresis using 1,250 ml adsorbers in a hypercholesterolemic obese patient: a case report.
    Bosch T; Lennertz A; Samtleben W
    Ther Apher; 2001 Oct; 5(5):358-63. PubMed ID: 11778920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis.
    Bosch T
    Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure.
    Bosch T; Thiery J; Gurland HJ; Seidel D
    Nephrol Dial Transplant; 1993; 8(12):1350-8. PubMed ID: 8159304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo biocompatibility of avidin-agarose: a new device for direct adsorption of biotinylated antibodies from human whole blood.
    Bosch T; Lennertz A; Duhr C; Fink E; Samtleben W
    Artif Organs; 2000 Sep; 24(9):696-704. PubMed ID: 11012539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions.
    Bosch T; Gahr S; Belschner U; Schaefer C; Lennertz A; Rammo J;
    Ther Apher Dial; 2006 Jun; 10(3):210-8. PubMed ID: 16817783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
    Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
    J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DALI-the first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results.
    Dräger LJ; Julius U; Kraenzle K; Schaper J; Toepfer M; Zygan K; Otto V; Steinhagen-Thiessen E
    Eur J Clin Invest; 1998 Dec; 28(12):994-1002. PubMed ID: 9893010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.